ENESTfreedom and ENESTop Update: Durable Treatment-Free Remission (TFR) at 96 Weeks after Nilotinib Treatment Cessation in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Autor: Radich, Jerald, Mahon, François-Xavier, Hochhaus, Andreas, Hughes, Timothy, Ailawadhi, Sikander, Lipton, Jeffrey, Gopalakrishna, Prashanth, Fellague-Chebra, Rafik, Deng, Weiping, Acharya, Sandip, Saglio, Giuseppe
Zdroj: In Clinical Lymphoma Myeloma and Leukemia September 2017 17 Supplement 2:S314-S315
Databáze: ScienceDirect